Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain

Completed · Phase 2 · Has a placebo group

Conditions studied: Pain

In brief

The purpose of this study is to evaluate the effectiveness of the Matrix Fentanyl Patch ZR-02-01 in providing pain relief.

Key facts

Study ID

NCT00108771

Run by

ZARS Pharma Inc.

People needed

202

Starts

2004-04-01

Expected to finish

2006-09-01

Last updated by the study team

2012-06-05

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults between the ages of 40 and 75 years of age suffering from moderate to severe chronic pain caused by osteoarthritis.

You may not qualify if…

• Patient is already taking chronic opioids or has a history of substance abuse or has a substance abuse disorder.

Where it is running

• Arizona Reserach Center — Phoenix, Arizona, United States
• Redpoint Research — Phoenix, Arizona, United States
• Sharp Rees-Stealy Medical Group — San Diego, California, United States
• San Diego Arthritis Medical Clinic — San Diego, California, United States
• Boling Clinical Trials — Upland, California, United States
• Radiant Research — Daytona Beach, Florida, United States
• Ocala Rheumatology — Ocala, Florida, United States
• Tampa Medical Group — Tampa, Florida, United States
• New Orleans Center for Clinical Research — New Orleans, Louisiana, United States
• Pain Trials Center - Brigham & Women's Hospital — Boston, Massachusetts, United States
• Phase III Clinical Trials — Fall River, Massachusetts, United States
• Beth Israel Medical Center — New York, New York, United States
• Analgesic Development Ltd. — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.